Raptor Pharmaceutica
Raptor Pharmaceutical to Present at Upcoming Investor Conference
02 juil. 2013 07h30 HE | Raptor Pharmaceutical Inc
NOVATO, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor's CEO, will present an overview of the company at...
Raptor's PROCYSBI(TM
Raptor's PROCYSBI(TM) Receives U.S. Orphan Drug Exclusivity
25 juin 2013 16h05 HE | Raptor Pharmaceutical Inc
NOVATO, Calif., June 25, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Office of Orphan Product Development at the Food and Drug Administration (FDA)...
Raptor's PROCYSBI(TM
Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
19 juin 2013 07h00 HE | Raptor Pharmaceutical Inc
NOVATO, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI™ (cysteamine bitartrate) delayed-release capsules are now available in...